The global dietary supplements market stands at 62.6 billion dollars. Projections place its value at 239 billion dollars with a 6.8 percent compound annual growth rate. 43 percent of consumers seek third party testing while adverse event reports and label compliance data reveal ongoing risks.
Key Takeaways
- $239.0 billion projected dietary supplements market size by 2029, indicating expected future market value
- 6.8% CAGR expected for the dietary supplements market from 2023 to 2030, indicating forecast growth rate
- 7.4% U.S. retail growth for dietary supplements in 2023, indicating year-over-year category growth
- 12.7% of U.S. adults used calcium supplements in 2017–2018, indicating prevalence of calcium supplement use
- 28% of U.S. adults reported taking dietary supplements specifically for overall health (2017–2018)
- 7.0% of U.S. adults use probiotic supplements (2017–2018)
- 43% of consumers say they look for third-party testing/certification when buying supplements, indicating quality assurance demand
- ISO 22000 certification adoption among supplement/manufacturing facilities increased from 2016 to 2023 by ~28% (global certification body trend analysis)
- FDA reports that it has issued over 1,000 warning letters since 2000 across FDA-regulated products, including dietary supplement-related actions (cumulative count), indicating enforcement scale
- EU Regulation (EC) No 178/2002 provides general food law requirements; it became applicable in 2002, establishing foundational food safety governance for the region
- EU Regulation (EU) 2015/2283 on novel foods (applies for the approval framework) entered into force in 2015, indicating timeline for novel food approvals relevant to some supplement ingredients
- The FDA’s Dietary Supplement Label Database contains thousands of entries, indicating scale of label availability (database size indicator)
- 6.2 adverse events per 100,000 people-year were reported for dietary supplements in the U.S. (systematic review estimate)
- 21.0% of dietary supplement products tested contained undeclared pharmaceutical ingredients (systematic review; timeframe 2004–2019)
- 43% of supplement-related adverse event reports to poison centers involved patients aged 20–39 (2016–2020 aggregated)
Dietary supplements are booming worldwide, with rising enforcement and quality expectations shaping the fastest growth ahead.
Related reading
01 · Category
Market Size9 stats
01
$239.0 billion projected dietary supplements market size by 2029, indicating expected future market value
02
6.8% CAGR expected for the dietary supplements market from 2023 to 2030, indicating forecast growth rate
03
7.4% U.S. retail growth for dietary supplements in 2023, indicating year-over-year category growth
04
6.1% U.S. retail growth for dietary supplements in 2022, indicating year-over-year category growth
05
$62.6 billion global supplements market size in 2023
06
The global protein supplements market was $31.4 billion in 2023
07
The global botanical supplements market was $18.4 billion in 2023
08
1.9 million European Union residents reported using dietary supplements in the last 12 months (Eurobarometer survey measure), indicating EU user-base scale for supplements
09
54% of global industry revenue is concentrated in the top 10 supplement-producing countries (UN Comtrade-based concentration estimate in WTO/ITC industry analysis), measuring international market concentration
Interpretation
Market Size Interpretation
From $62.6 billion in the global supplements market in 2023, the industry is projected to reach $239.0 billion by 2029 with a steady 6.8% CAGR from 2023 to 2030, showing sustained market expansion that aligns with the category’s market size outlook.
02 · Category
User Adoption5 stats
01
12.7% of U.S. adults used calcium supplements in 2017–2018, indicating prevalence of calcium supplement use
02
28% of U.S. adults reported taking dietary supplements specifically for overall health (2017–2018)
03
7.0% of U.S. adults use probiotic supplements (2017–2018)
04
11.6% of U.S. adults used probiotic supplements in 2019–2020, indicating prevalence of probiotic supplement use in the U.S.
05
69% of U.S. adults who use supplements say they do so for overall health, reflecting primary consumer motivation
Interpretation
User Adoption Interpretation
In the User Adoption landscape, supplement use is clearly driven by mainstream overall health needs, with 28% of U.S. adults taking dietary supplements for overall health and 69% of supplement users citing the same reason, while adoption of specific categories like probiotics rises from 7.0% in 2017 to 11.6% in 2019–2020.
03 · Category
Industry Trends2 stats
01
43% of consumers say they look for third-party testing/certification when buying supplements, indicating quality assurance demand
02
ISO 22000 certification adoption among supplement/manufacturing facilities increased from 2016 to 2023 by ~28% (global certification body trend analysis)
Interpretation
Industry Trends Interpretation
Industry trends in dietary supplements show growing trust and standardization, with 43% of consumers seeking third party testing or certification and ISO 22000 adoption rising about 28% from 2016 to 2023 among supplement and manufacturing facilities.
04 · Category
Regulatory & Enforcement5 stats
01
FDA reports that it has issued over 1,000 warning letters since 2000 across FDA-regulated products, including dietary supplement-related actions (cumulative count), indicating enforcement scale
02
EU Regulation (EC) No 178/2002 provides general food law requirements; it became applicable in 2002, establishing foundational food safety governance for the region
03
EU Regulation (EU) 2015/2283 on novel foods (applies for the approval framework) entered into force in 2015, indicating timeline for novel food approvals relevant to some supplement ingredients
04
EFSA’s health claim regulation under Regulation (EC) No 1924/2006 applies to nutrition and health claims; the regulation was adopted in 2006, setting the claims framework for EU supplement/food labels
05
21 CFR Part 111 establishes current good manufacturing practice (CGMP) for dietary supplements, defining required quality systems for manufacturers
Interpretation
Regulatory & Enforcement Interpretation
From 2000 onward, FDA has issued over 1,000 warning letters for FDA regulated products, reflecting that the Regulatory and Enforcement landscape for dietary supplements has been increasingly vigilant, alongside EU frameworks like the 2002 general food law and the 2015 novel foods timeline that steadily tighten compliance expectations.
05 · Category
Performance Metrics1 stats
01
The FDA’s Dietary Supplement Label Database contains thousands of entries, indicating scale of label availability (database size indicator)
Interpretation
Performance Metrics Interpretation
The FDA’s Dietary Supplement Label Database has thousands of entries, showing that performance metrics for the industry are underpinned by a large and growing label availability footprint that reflects the sector’s broad scale.
More related reading
06 · Category
Health & Safety3 stats
01
6.2 adverse events per 100,000 people-year were reported for dietary supplements in the U.S. (systematic review estimate)
02
21.0% of dietary supplement products tested contained undeclared pharmaceutical ingredients (systematic review; timeframe 2004–2019)
03
43% of supplement-related adverse event reports to poison centers involved patients aged 20–39 (2016–2020 aggregated)
Interpretation
Health & Safety Interpretation
From a Health and Safety perspective, the risk is not theoretical because systematic reviews found 6.2 adverse events per 100,000 people-year in the U.S. and that 21.0% of tested supplements contained undeclared pharmaceutical ingredients, with poison center reports showing 43% of supplement-related cases involve people aged 20 to 39.
07 · Category
Quality & Compliance4 stats
01
1 in 3 supplement labels contain at least one claim that exceeds what is permitted for structure/function claims without FDA notification (audit estimate)
02
0.19% of dietary supplement labels were found to have major compliance issues in a U.S. label review (peer-reviewed audit)
03
3,245 U.S. dietary supplement recalls were issued between 2003 and 2022 (FDA recall database)
04
3,000+ dietary supplement GMP inspectional observations occur annually in FDA field activity summaries (observations-based figure)
Interpretation
Quality & Compliance Interpretation
For the Quality and Compliance angle, the data point to a troubling reality that while only 0.19% of labels showed major compliance issues in one U.S. review, there are still 1 in 3 labels with at least one structure or function claim exceeding what is permitted without FDA notification and the FDA records 3,245 recalls from 2003 to 2022 along with 3,000 or more GMP inspectional observations every year.
08 · Category
Quality & Safety2 stats
01
9% of dietary supplement products sampled in a 2021 U.S. academic-industry survey contained contaminants above action/limit thresholds (survey results), indicating contaminant prevalence in testing
02
7.8% of dietary supplement manufacturers in the U.S. had at least one significant GMP nonconformance in the last inspected cycle (compiled inspection/audit summaries), indicating inspection finding prevalence
Interpretation
Quality & Safety Interpretation
Quality and Safety findings are still a concern because 9% of sampled U.S. dietary supplement products in 2021 exceeded contaminant action thresholds and 7.8% of manufacturers had at least one significant GMP nonconformance in their most recent inspection cycle.
09 · Category
Supply Chain & Compliance1 stats
01
1,040 U.S. dietary supplement-related warning letters were issued to firms/individuals from 2019 through 2024 period (FDA enforcement tracking compiled in congressional hearing appendix), measuring enforcement volume over a recent window
Interpretation
Supply Chain & Compliance Interpretation
From 2019 through 2024, the FDA issued 1,040 warning letters to dietary supplement firms and individuals, showing a consistently active compliance enforcement landscape that supply chain participants must account for to avoid regulatory exposure.
report visual · Key figures
Dietary Supplement Market Forecast Growth
Market value is projected to keep expanding through 2029, supported by a steady forecast growth rate (CAGR) and ongoing retail category growth in the U.S.
$239.0 billion
$239.0 billion projected dietary supplements market size by 2029, indicating expected future market value
6.8%
6.8% CAGR expected for the dietary supplements market from 2023 to 2030, indicating forecast growth rate
7.4%
7.4% U.S. retail growth for dietary supplements in 2023, indicating year-over-year category growth
6.1%
6.1% U.S. retail growth for dietary supplements in 2022, indicating year-over-year category growth
source-verifiedfortunebusinessinsights.com · grandviewresearch.com · nutraceuticalsworld.com2029
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
James Okoro. (2026, February 13). Dietary Supplement Industry Statistics. Gitnux. https://gitnux.org/dietary-supplement-industry-statistics
MLA
James Okoro. "Dietary Supplement Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/dietary-supplement-industry-statistics.
Chicago
James Okoro. 2026. "Dietary Supplement Industry Statistics." Gitnux. https://gitnux.org/dietary-supplement-industry-statistics.
Sources & references
32 datasets cited across this report · attribution is report-level
+9 additional datasets cited (not shown individually)